Chapter 6: Enzymes: The Catalysts of Life

Welcome to Last Minute Lecture.

This free chapter overview is designed to help students review and understand key concepts.

These summaries supplement not replaced the original textbook and may not be redistributed or resold.

For complete coverage, always consult the official text.

Welcome back to The Deep Dive, where our goal is to deliver profound understanding, a true shortcut to being well -informed, by cracking open, dense sources and distilling the most surprising and vital information.

Our sources today plunge us into the machinery that governs all life, focusing on chapter six of cell biology, enzymes.

And this dive answers arguably the most fundamental question about cellular life.

Why are complex, high -energy biological molecules stable?

Why are you not fontaniously dissolving right now?

That's a great hook because it highlights this thermodynamic paradox.

We previously learned about the change in free energy, Agee, which defines if a reaction is possible.

If Agee is negative, the reaction is exergonic, meaning it releases energy and is theoretically spontaneous.

Take one of the cell's most important molecules, ATP.

Hydrolyzing ATP, breaking it down, is highly exergonic.

It releases about negative 7 .3 calmol mol under standard conditions.

So thermodynamically, that ATP molecule is unstable.

It should just fall apart in water.

It should immediately break down to reach its lower energy state, but it doesn't.

Right.

If you mix pure ATP into water, it just sits there for days, maybe even weeks.

The chemical reaction that is supposed to drive our muscles and brains simply doesn't happen on its own.

And this contradiction,

that a reaction can happen but practically won't, is the central riddle.

Thermodynamics gives us the starting line and the finish line.

But it tells us nothing about the path in between.

Exactly.

It says nothing about the rate or kinetics of that process.

So if the direction is set by Agee, the missing piece, the cellular key that manages the rate, must be the enzyme.

There are the specific biological catalysts that determine whether a thermodynamically possible reaction will actually happen at a speed that's compatible with life.

Our mission today is to explore the four pillars of enzyme action.

First, how they manage the energy barriers that keep us stable.

Second, how their structure enables phenomenal specificity.

Third, how we quantify their behavior using kinetics.

And finally, how the cell regulates their activity with astonishing precision.

Okay, let's start with that hurdle itself, the energy barrier.

We have to understand the concept of activation energy, or EAF.

EA1 is the minimum amount of energy that reactant molecules must absorb to even get a reaction started.

Think of it as the price of admission.

So once the molecules absorb this energy, they hit this really unstable, short -lived intermediate stage.

That's it.

We call it the transition state.

And the free energy of that transition state is higher than the reactants you started with.

It's the very peak of that energy hill we're talking about.

Only the molecules that make it to the top of that peak can actually convert to product.

And that's where the concept of the meta -stable state becomes the crux of cellular stability.

For nearly all molecules essential to life, glucose, DNA,

ATP, the EA barrier for their spontaneous breakdown is just incredibly high.

So at normal body temperature, almost nothing has enough energy to get over that hump.

A tiny, minuscule fraction, yeah.

So we exist in this state of potential energy release.

The molecules are thermodynamically unstable.

They should react.

But they're kinetically stable.

They don't react quickly because that huge EA -OR barrier is in the way.

And thank goodness it is.

If those barriers were suddenly removed, all our complex biomolecules would just rapidly degrade.

Everything would move toward chemical equilibrium.

And equilibrium is death for a cell.

It's totally incompatible with the highly ordered structure required for life.

The high EA barriers are literally what allow life to maintain its structure.

The sources use a fantastic analogy for this.

The egg in a bowl on the edge of a table.

Oh, that's a great one.

The floor is the low energy state.

The egg wants to be on the floor.

She's as favorable.

But the little lip of the bowl is the EA barrier.

You have to put in a little bit of energy to lift the egg over that lip before gravity or thermodynamics takes over.

That perfectly captures it.

So if the cell needs a reaction to happen fast, it has to find a way to get more molecules over that barrier.

And there are really only two ways to do that.

Okay, so option one is thermal activation.

Just turn up the heat.

Right.

You raise the temperature.

You increase the kinetic energy of all molecules.

And a greater proportion of them now have enough energy to get over the barrier.

But that's obviously not going to work for a living thing.

Not at all.

We're isothermal.

We operate in a very narrow temperature range.

If you increase the temperature enough to catalyze digestion, you would simultaneously denature and destroy every protein in your body.

We can't boil the soup to make it digest faster.

Which leaves us with the only viable biological alternative,

catalytic activation.

Instead of raising the energy of the reactants, we introduce a catalyst that just lowers the EA -DAO barrier itself.

So it's like digging a tunnel through the mountain instead of climbing over it.

Exactly.

The catalyst provides an alternative reaction pathway.

It forms a temporary, reversible complex with the substrate, which stabilizes the transition state.

And because the path is easier, many more molecules, even at low temperatures, can overcome the barrier.

And crucially, the catalyst is never used up.

It comes out of the reaction totally unchanged, ready for the next one.

Before we move on, there is one very strange counterintuitive mechanism we have to mention.

Quantum tunneling.

It sounds like science fiction.

It kind of is.

In certain reactions, especially dehydrogenation, a hydrogen atom can actually tunnel through the EAA barrier instead of climbing over it.

How does that even work?

It's because particles that small also have wave -like properties.

It's a bizarre exception, and what's interesting is that when tunneling is the main mechanism, the reaction rate becomes almost independent of temperature, which is highly unusual.

But the real power is in the rate enhancement of regular catalysis.

Let's use the decomposition of hydrogen peroxide, TEXO22, as our benchmark.

Good idea.

That reaction is naturally slow.

If we add a simple inorganic catalyst like an iron ion, TEX3 plus 2, we see a big rate increase, about 30 ,000 times faster.

Which is pretty good, but the cell uses the iron -containing enzyme catalase, and when catalase is there, the rate goes up.

What is it?

Approximately 100 million times faster.

That's 10 to the 8th power.

Wow.

100 million.

The difference between the simple ion and the biological enzyme is what you need to focus on.

Enzymes can enhance reaction rates anywhere from 10 million up to 10 to the 17th That phenomenal specific efficiency is why they are the bedrock of all metabolism.

Okay, since we've established enzymes are essential, let's talk about the three universal rules for how any catalyst works.

Okay.

Rule one,

they lower the activation energy, which increases the reaction rate.

Rule two, they form a temporary transient complex with the substrate to stabilize that transition state.

And rule three, which I think is often misunderstood,

catalysts only change the rate.

They have absolutely no effect on the thermodynamics.

That's a critical point.

They can't alter the air.

They can't change where the final equilibrium lies.

They just help you get to equilibrium much, much faster.

So for a long time, scientists just assumed all enzymes were proteins.

James Sumner proved it in 1926 when he crystallized urease.

But that understanding got a major shock in the 1980s with the discovery of ribozymes?

Uh, yes.

Catalytic RNA.

A total game changer.

But let's stick with protein enzymes for on the site of action, the active site.

Right.

This is the specialized three -dimensional pocket on the enzyme surface where all the magic happens.

And what's so cool is that the amino acid residues that form this site are almost never next to each other in the linear protein chain.

Oh, so that's why the 3D folding, the tertiary structure is so critical.

The folding process brings these specific residues, which might be hundreds of amino acids apart, into perfect alignment to create that catalytic pocket.

Exactly.

Take lysozyme.

It's a small protein, but only a couple of residues like glutamate 35 and aspartate 52 do the actual work and they have to be positioned perfectly.

Now, many enzymes need a little help.

They're not just protein chains.

They require non -protein assistance.

We call these cofactors or prosthetic groups.

A prosthetic group is a non -protein component that's really tightly bound, sometimes even covalently.

These are often metal ions like zinc or iron.

Why metal ions?

Because they are fantastic at accepting electrons, which is a chemical job that no standard amino acid side chain can do very well.

And then we have the coenzymes, which are small organic molecules often derived from vitamins.

This is the direct link to nutrition.

It is.

Coenzymes like the derivatives of niacin and riboflavin are essential for oxidizing glucose.

They act as carriers for electrons and hydrogen.

And because we can't make them ourselves, we have to get them from our diet.

This precise active site architecture leads to the hallmark of enzymes, their incredible specificity.

This is probably the biggest difference between them and simple inorganic catalysts.

Remember our hydrogenation example.

A platinum catalyst will hydrogenate any carbon -carbon double bond it finds.

That's chemical anarchy for a cell.

Whereas a cell needs surgical precision.

Exactly.

Take succinate dehydrogenase.

It only acts on succinate.

It will completely reject malate, which is a structural isomer.

Same formula, just arranged differently.

It doesn't fit the active site, so it's ignored.

But sometimes you don't want absolute specificity, right?

You might want group specificity.

Right.

A digestive enzyme like carboxypeptidase A is a good example.

It just needs to chop the last amino acid off of any protein.

Its job is bulk digestion, so it needs to be more flexible.

With thousands of these things, we obviously need a classification system.

That's the enzyme commission or EC system.

The EC system puts all known enzymes into six major classes based on the type of reaction they catalyze, like oxidoreductase for redox reactions, hydrolases for breaking bonds with water, and so on.

Okay, let's shift to mechanics.

How the enzyme actually interacts with the substrate.

For decades, the dominant idea was the lock and key model.

Proposed by Emil Fischer in 1894.

A very static view.

The substrate is the key, the active site is the lock, and they fit perfectly.

It was great for explaining specificity, but it had a flaw.

Right, huge one.

It didn't explain the catalysis.

If the fit is perfect from the start, there's no energy incentive to actually break the bonds.

So that led to the induced fit model from Daniel Koshlin in 1958.

This one is dynamic.

Totally dynamic.

The initial binding of the substrate is just the beginning.

That binding triggers a conformational change in the enzyme.

The enzyme literally changes shape.

It does.

It wraps around the substrate, and in doing so, it actively distorts the substrate's bonds, stressing them and pushing the molecule into that high -energy transition state.

We can actually see this happen.

With hexokinase, for example, which starts glucose metabolism.

Yes, it has two domains that physically clamp down around the glucose molecule when it binds.

Like clamshell closing.

So once it's bound and the fit is induced, the enzyme uses a few methods to activate the substrate.

Three main ones.

Bond distortion, which is that mechanical stress we just talked about.

Proton transfer, using acetic or basic residues to shuttle protons around.

And electron transfer, often involving those metal cofactors.

So if we walk through the whole cycle with an enzyme like sucrose.

Okay.

First, random collision leads to specific binding.

Second, that binding triggers the induced fit, which lowers the transition state energy.

Third, the chemical conversion happens super fast.

Fourth, the products leave the active site.

And finally, the enzyme snaps back to its original shape, ready for the next customer.

Thousands of times a second.

Before we jump into the numbers, let's circle back to the ribozymes.

We can't overlook their evolutionary importance.

Absolutely not.

The discoveries by Schick and Altman in the 80s were revolutionary.

Schick showed that a precursor RNA in a protozoan could splice itself autocatalysis with no protein help at all.

And Altman showed that the RNA part of another enzyme was the actual catalyst.

It just shattered the old dogma that only proteins could be enzymes.

And the most profound implication is in the ribosome itself.

The machine that makes all the proteins.

Right.

For years, everyone assumed a protein in the ribosome was what formed the peptide bond.

But it turns out the catalytic core of the ribosome is RNA.

Which is huge evidence for the RNA world hypothesis.

It's the smoking gun.

It suggests that early in evolution, RNA did both jobs.

It carried genetic information.

And it catalyzed reactions long before proteins and DNA came on the scene.

Okay.

Now we're transitioning from the how to the how fast.

We are entering the realm of enzyme kinetics.

And we have to focus on the initial reaction velocity or thing dollar.

Yeah.

We always make sure of evidence right at the beginning of the reaction.

We want to capture the rate when the substrate concentration is still high and effectively constant and before any product is built up to push the reaction backward.

To really get the feel for this, let's use the analogy from our sources.

The monkeys and the peanuts.

I love this analogy.

Okay.

Imagine 10 expert monkeys, our enzymes,

shelling peanuts, our substrates.

And we plot the rate of shelled peanuts, our velocity against the number of peanuts in the room, our substrate concentration.

Okay.

Scenario one, very few peanuts.

The room is mostly empty.

The rate limiting step is the monkey finding a peanut.

If that takes nine seconds and shelling takes one second, the total cycle is 10 seconds.

The rate is low.

But if you double the peanuts, the finding time gets cut in half and the rate almost doubles.

It's a nearly linear relationship at the beginning.

Exactly.

Now scenario two,

we just dump truckloads of peanuts into the room.

They're everywhere.

The time to find a peanut is now basically zero.

But the time to shell the peanut is fixed.

The monkey can only work so fast.

Right.

The shelling takes one second, no matter what.

So the maximum rate for that monkey is one peanut per second.

For all 10 monkeys, it's 10 peanuts per second.

You've hit a plateau.

You've reached saturation.

And that gives us the classic hyperbolic curve.

It's steep at the beginning when binding is limited.

And then it flattens out at the top when the catalysis itself is the limit.

This hyperbolic relationship is the universal signature of enzyme -catalyzed reactions.

And it's described mathematically by the Michielus -Menten equation.

This equation introduces two absolutely critical kinetic constants, Vmax and 3 Aber.

Let's define them.

Vmax is the maximum velocity.

It's the theoretical top speed when the enzyme is completely saturated with substrate.

It's really a measure of the enzyme's turnover speed, and depends on how much enzyme you have.

And Gollomolars, the Michielus constant.

This is defined as the substrate concentration you need to reach exactly half of Vmax.

And the biological significance of Vmax is huge.

It's often a proxy for the enzyme's affinity for its substrate.

A low Dommelir means the enzyme hits half speed at a low substrate concentration.

That indicates high affinity.

So it's very effective, even when resources are scarce.

Precisely.

A high Dommelir means low affinity.

You need a lot of substrate to get it going.

And if we look at just one single enzyme molecule, we get the turnover number, or Texcomer.

Right.

Texco is the maximum number of substrate molecules one enzyme molecule can convert per second.

It's a true measure of catalytic efficiency.

Take carbonic anhydrase,

Texco is a million dollars per second.

A million substrates every second.

It's just staggering.

It's working at pretty much the physical limit of how fast molecules can even diffuse into the active site.

Okay, so the Michielus -Menten curve is great conceptually, but it's not great for experience, right?

Yeah.

It's hard to actually pinpoint Vmax -Dohler when the curve just gets flatter and flatter.

Exactly.

It's almost impossible to accurately extrapolate it, which is why Hans Lineweaver and Dean Burke introduced the double reciprocal plot.

So they just linearized the equation by plotting the reciprocal of velocity, one over five dollars, against the reciprocal of substrate concentration one over S.

And it makes everything clean and defined.

The y -intercept is one over Vmax.

The x -intercept is negative one over Kamabalers.

It gives you a really precise way to calculate those parameters from just a few data points.

Okay, so enzymes aren't just controlled by how much substrate is around, they're also powerfully influenced by inhibitors.

Yes, and this is critical for controlling metabolism, and it's the basis for like half of modern pharmacology.

We can break them down into two big categories.

First, irreversible inhibition.

This is when the inhibitor binds covalently, permanently killing the enzyme's activity.

These are often toxins, like heavy metals or nerve gases.

But they can also be good things, like aspirin.

Right.

Aspirin irreversibly binds and inactivates the COX1 enzyme that causes inflammation.

And penicillin is an irreversible inhibitor that blocks an enzyme bacteria need to build their cell walls, a brilliant example of targeted chemical warfare.

Then we have reversible inhibition, which is non -covalent.

The two major types here are competitive and non -competitive.

Competitive inhibition is the easy one to picture.

The inhibitor looks like the substrate and binds directly to the active site.

They're literally competing for the same spot.

And the key thing here is you can overcome it by just adding more substrate.

Exactly.

You flood the system with substrate, and it eventually outcompetes the inhibitor.

On a Lineweaver -Burk plot, this increases the apparent going wall, but it has no effect on Vmax dollar.

If you add enough substrate, you can still reach the same top speed.

Okay, then there's non -competitive inhibition.

This works differently.

The inhibitor binds to an allosteric site, a spot that's not the active site.

This binding causes a shape change that just makes the enzyme less efficient.

It slows it down.

And because they're not competing for the same site, adding more substrate does nothing.

Absolutely nothing.

The enzyme is just fundamentally slower.

Kinetically, this decreases Vmax, but it leaves allomolers unchanged.

The affinity for the substrate is the same, but the enzyme's ability to process it is crippled.

We have a fantastic real -world application of this in medicine.

ACE inhibitors for controlling blood pressure.

Yes, and this story starts with the venom of the Brazilian pit viper.

Scientists found peptides in the venom that caused a massive drop in blood pressure.

And they figured out these peptides were inhibiting an enzyme called angiotensin -converting enzyme, or ACE.

Right, ACE is a central player in the body's system for raising blood pressure.

When pressure drops, a hormone called renin kicks off a chain reaction, producing something called angiotensin -the -fast.

And ACE's job is to convert that into angiotensin -the -second.

And angiotensin -the -second is a super -powerful vasoconstrictor.

It squeezes your blood vessels, raising blood pressure.

But that's not all ACE does.

Right, it has a second job.

It also destroys a peptide called bradykinin, which is a vasodilator.

It lowers blood pressure.

So ACE raises blood pressure in two ways.

It makes a constrictor, and it destroys a dilator.

So inhibiting ACE is an incredibly effective way to lower blood pressure.

It's a perfect therapeutic target.

Drugs like captopril, which were designed based on the viper venom, are highly specific competitive inhibitors.

They look like the transition state of the reaction.

So they get into the active site and just block it.

They block it, which prevents angiotensin -the -second from being made, and it allows the pressure -lowering bradykinin to stick around longer.

It's a powerful one -two punch for treating hypertension.

This transition from kinetics to ACE inhibitors brings us perfectly to our final and most complex section,

enzyme regulation.

Right.

A cell can't just run all its enzymes at VMAX all the time.

That would be chaos.

It needs constant fine -tuning.

And simple substrate -level regulation, just responding to how much substrate or product is around, is often not enough.

For complex pathways, you need master switches.

And typically, the enzyme that catalyzes the first committed step of a pathway is the one that's most heavily regulated.

If you control the entrance, you control the whole flow.

Exactly.

And the two most sophisticated control methods are allosteric regulation and covalent modification.

Let's start with allosteric.

The most common form is feedback inhibition.

This is such an elegant system.

The final product of a long pathway comes all the way back and acts as a specific allosteric inhibitor of the very first enzyme in that pathway.

So if the cell has enough of the product, the product itself shuts down its own assembly line.

It's a perfect supply and demand loop.

When the product gets used up, the inhibition stops, and the pathway turns back on instantly.

The word allosteric means another site.

So these enzymes are different.

They're specialized machines, usually large multi -subunit proteins,

and they exist in an equilibrium between two shapes.

The T, or tense state, which is low affinity and inactive.

And the R, or relaxed state, which is high affinity and active.

And an allosteric effector is a small molecule that binds to this other regulatory site and basically locks the enzyme in one of those two states.

Exactly.

An inhibitor stabilizes the T state, making it less active.

An activator stabilizes the R state, making it more active.

And these enzymes usually have separate catalytic subunits, where the reaction happens, and regulatory subunits, where the effectors bind.

And that multi -subunit structure allows for a phenomenon called cooperativity.

This is where binding at one site affects the other sites.

Right.

With positive cooperativity, when one substrate molecule binds, it flips its subunit to the R state, which then encourages the other subunits to flip to the R state as well.

It makes them more receptive.

Which gives you a sigmoidal or S -shaped velocity curve instead of a hyperbola.

And that S -shape makes the enzyme incredibly sensitive to small changes in substrate concentration right around a certain threshold.

It acts like a very responsive switch.

Okay.

Beyond allosteric shifts, there's covalent modification.

The most common example being phosphorylation.

Yes.

Phosphorylation is adding a bulky, negatively charged phosphoryl group from ATP onto the enzyme.

The enzymes that do this are called protein kinases.

And taking it off, dephosphorylation is done by protein phosphatuses.

So this is basically a reversible on -off switch.

It's a very common and very rapid metabolic switch.

The classic example is glycogen phosphorylase, the enzyme that breaks down glycogen to release glucose.

It exists in an inactive B form and an active A form.

When the cell gets a hormonal signal like adrenaline,

a kinase cascade gets activated.

The final kinase phosphorylates the enzyme, turning it from the inactive B form to the active A form, and suddenly you're releasing tons of glucose for energy.

And what's really amazing is the layered control here.

It's incredible.

The active A form of that same enzyme is also allosterically inhibited by glucose and ATP.

So even if it's been turned on by phosphorylation, if the cell already has enough glucose, that glucose will bind to an allosteric site and shut it right back down.

The cell has multiple override systems.

Finally, there's an irreversible type of covalent modification, proteolytic cleavage.

This is a mechanism of delayed activation.

The enzyme is made as an inactive precursor called a zymogen.

And to activate it, you have to surgically snip off a piece of it.

A one -time, irreversible cut by another protease.

This is critical for digestive enzymes.

The pancreas makes things like trypsin and chymotrypsin.

If they were active inside the pancreas, they would digest the organ itself.

That would be bad.

Very bad.

So instead, they're secreted into the small intestine as inactive zymogens, like trypsinogen.

There, an enzyme called anerocanase makes the first cut, activating trypsin.

And once trypsin is active, it rapidly activates all the other zymogens.

Maximum digestive power, but only where it's safe and needed.

This has been an incredibly deep exploration of the cell's master machines.

We resolved that fundamental paradox.

EGIS sets the potential, but enzymes, by lowering the EAI barrier, govern the reality.

We detailed how the active site achieves its specificity through the dynamic -induced FIT model, and how the discovery of ribozymes completely redefined our understanding of catalysis and gave us the RNA world hypothesis.

Quantitatively, we learned that vimax is the top speed, and line knowledge is all about affinity.

And we can now see how different inhibitors leave unique signatures on a line -weaver -Burk plot, telling us exactly how they work.

And finally, we saw how the cell uses these sophisticated overlapping regulatory systems.

From rapid allosteric feedback, to reversible phosphorylation switches, and even the delayed activation of zymogens, to maintain that dynamic, non -equilibrium steady state we call life.

The complexity of these overlapping controls is just truly astounding.

The cell's metabolic potential isn't just defined by what enzymes it has, but by the astonishing precision with which it regulates their speeds.

It makes you realize that survival isn't just about having the right ingredients, it's about timing.

Making sure every single reaction happens at the right speed, in the right place, at exactly the right moment.

Thank you for diving deep with us.